These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20735214)

  • 21. [High-performance society and doping].
    Gallien CL
    Ann Pharm Fr; 2002 Sep; 60(5):296-302. PubMed ID: 12378137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definition and outcome of a curriculum to prevent disordered eating and body-shaping drug use.
    Elliot DL; Moe EL; Goldberg L; DeFrancesco CA; Durham MB; Hix-Small H
    J Sch Health; 2006 Feb; 76(2):67-73. PubMed ID: 16466469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inside athletes' minds: preliminary results from a pilot study on mental representation of doping and potential implications for anti-doping.
    Petróczi A; Mazanov J; Naughton DP
    Subst Abuse Treat Prev Policy; 2011 May; 6():10. PubMed ID: 21599981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone abuse in sports: the antidoping perspective.
    Barroso O; Mazzoni I; Rabin O
    Asian J Androl; 2008 May; 10(3):391-402. PubMed ID: 18385901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Popular drugs in sport: descriptive analysis of the enquiries made via the Drug Information Database (DID).
    Petróczi A; Naughton DP
    Br J Sports Med; 2009 Oct; 43(11):811-7. PubMed ID: 18981038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implicit motives and basic need satisfaction in extreme endurance sports.
    Schüler J; Wegner M; Knechtle B
    J Sport Exerc Psychol; 2014 Jun; 36(3):293-302. PubMed ID: 24918312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behaviour of reticulocyte counts and immature reticulocyte fraction during a competitive season in élite athletes of four different sports.
    Banfi G; Del Fabbro M
    Int J Lab Hematol; 2007 Apr; 29(2):127-31. PubMed ID: 17474885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of performance- and image-enhancing substances among recreational athletes: a quantitative analysis of inquiries submitted to the Danish anti-doping authorities.
    Bojsen-Møller J; Christiansen AV
    Scand J Med Sci Sports; 2010 Dec; 20(6):861-7. PubMed ID: 19843266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidoping attitudes among elite athletes: a cross sectional study in biathlon using a suitably developed questionnaire.
    Lamberti N; Malagoni AM; Felisatti M; Caracciolo S; Resch N; Litmanen H; Dalfollo D; Jeannier P; Zhukovskaja L; Carrabre JE; Manfredini F
    J Sports Med Phys Fitness; 2017 May; 57(5):610-623. PubMed ID: 27139792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary supplementation of high-performance Canadian athletes by age and gender.
    Erdman KA; Fung TS; Doyle-Baker PK; Verhoef MJ; Reimer RA
    Clin J Sport Med; 2007 Nov; 17(6):458-64. PubMed ID: 17993788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The social-cognitive mechanisms regulating adolescents' use of doping substances.
    Lucidi F; Zelli A; Mallia L; Grano C; Russo PM; Violani C
    J Sports Sci; 2008 Mar; 26(5):447-56. PubMed ID: 18274942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of performance level on dietary supplementation in elite Canadian athletes.
    Erdman KA; Fung TS; Reimer RA
    Med Sci Sports Exerc; 2006 Feb; 38(2):349-56. PubMed ID: 16531906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moral disengagement and associated processes in performance-enhancing drug use: a national qualitative investigation.
    Boardley ID; Grix J; Dewar AJ
    J Sports Sci; 2014; 32(9):836-44. PubMed ID: 24405120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabis use to enhance sportive and non-sportive performances among French sport students.
    Lorente FO; Peretti-Watel P; Grelot L
    Addict Behav; 2005 Aug; 30(7):1382-91. PubMed ID: 16022934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized response estimates for doping and illicit drug use in elite athletes.
    Striegel H; Ulrich R; Simon P
    Drug Alcohol Depend; 2010 Jan; 106(2-3):230-2. PubMed ID: 19740612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New provisions for prevention and fight against doping].
    Boulu RG
    Ann Pharm Fr; 2002 Sep; 60(5):291-5. PubMed ID: 12378136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doping droops.
    Chaturvedi A; Chaturvedi H; Kalra J; Kalra S
    Indian J Physiol Pharmacol; 2007; 51(2):118-30. PubMed ID: 18175655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doping use meta-analysis: science seasoned with moralistic prejudice.
    Arandjelović O
    Sports Med; 2015 Mar; 45(3):443-4. PubMed ID: 25655374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.